Actionable news
All posts from Actionable news
Actionable news in SGEN: Seattle Genetics, Inc.,

Seattle Genetics's President and CEO just cashed-in 800 options

Clay B Siegall, Seattle Genetics's President and CEO and a director of the company, recently cashed-in 800 options. The options were exercised at $10.20, while the disposals took place at $40.00 per share, on April 25, 2016. Siegall continues to hold 584,060 shares of the company. Siegall operates out of Bothell, WA. Some additional info was provided as follows:

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Shares vested at a rate of 25% on 5/25/08 and monthly thereafter until all the shares were fully vested on 5/25/11.

The above information was disclosed in a filing to th e SEC. To see the filing, click here.

To receive a free e-mail notification whenever Seattle Genetics makes a similar move, sign up!

Other recent filings from the company include the following:

Seattle Genetics's President and CEO just cashed-in 7,618 options - April 7, 2016

Seattle Genetics releases salary data. CEO sees compensation rise 0% - April 6, 2016